Search Results

Filter
  • 1-10 of  60 results for ""Carcinoma, Non-Small-Cell Lung genetics""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox.

  • Authors : Qu M; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Department of Oncology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/radiotherapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2023 Dec; Vol. 27 (12), pp. 393-405.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/ HK2 Axis in Cisplatin-Resistant Nonsmall Cell Lung Carcinoma.

  • Authors : Shi Q; Department of Oncology, Affiliated Hospital of Xiangnan University, Chenzhou, China.; Ji T

Subjects: Exosomes*/Exosomes*/Exosomes*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Oct; Vol. 38 (8), pp. 558-571. Date of Electronic Publication: 2021 Mar 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p.

  • Authors : Wang X; Department of Pharmacy Intravenous Admixture Service, Weifang People's Hospital, Weifang, China.; Wang H

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 293-304. Date of Electronic Publication: 2021 Aug 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review.

  • Authors : Sidrak MMA; Nuclear Medicine, Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.; De Feo MS

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 May; Vol. 38 (4), pp. 232-245. Date of Electronic Publication: 2023 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements.

  • Authors : Cullot G; Bordeaux Institute in Oncology-BRIC-MoTRIL Team, INSERM U1312, University of Bordeaux, Bordeaux, France.; Department of Biology, ETH Zurich, Zurich, Switzerland.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/diagnosis ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnosis

  • Source: The CRISPR journal [CRISPR J] 2023 Apr; Vol. 6 (2), pp. 140-151. Date of Electronic Publication: 2023 Mar 13.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic

Record details

×
Academic Journal

Effects of p450 Polymorphisms on the Clinical Outcomes of Gefitinib Treatment in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer.

  • Authors : Fan R; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2022 Dec; Vol. 26 (12), pp. 582-588.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

Inhibition of Epidermal Growth Factor Receptor Signaling by Antisense Oligonucleotides as a Novel Approach to Epidermal Growth Factor Receptor Inhibition.

  • Authors : Madanayake TW; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Welsh EA

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2022 Oct; Vol. 32 (5), pp. 391-400. Date of Electronic Publication: 2022 Jul 20.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic

Record details

×
Academic Journal

Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?

  • Authors : Bratova M; Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Lung Neoplasms*

  • Source: Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2022 Oct; Vol. 11 (5), pp. 451-458. Date of Electronic Publication: 2021 Nov 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic

Record details

×
Academic Journal

Epidermal Growth Factor Receptor Mutation Mechanisms in Nonsmall Cell Lung Cancer by Transcriptome Sequencing.

  • Authors : Yu M; Department of Oncology Medicine, and Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.; Huo S

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2022 Sep; Vol. 37 (7), pp. 560-568. Date of Electronic Publication: 2021 May 18.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells.

  • Authors : Liu Z; Department of Respiratory Diseases, Suzhou Municipal Hospital, Suzhou, China.; Department of Gastroenterology, Xiangcheng People's Hospital, Suzhou, China.

Subjects: Antigens, Differentiation*/Antigens, Differentiation*/Antigens, Differentiation*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2022 Jul-Aug; Vol. 26 (7-8), pp. 351-359.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
  • 1-10 of  60 results for ""Carcinoma, Non-Small-Cell Lung genetics""